🎁 Black Friday: up to 50% off of annual plans
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
63.34
-1.54 (-2.37%)
At close: Nov 20, 2026, 4:00 PM EST
63.65
+0.31 (0.49%)
After-hours: Nov 20, 2026, 7:56 PM EST

TG Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
897.76616.29329233.662.796.69
Revenue Growth
68.78%87.32%40.80%8290.02%-58.36%4300.66%
Cost of Revenue
154.93100.7138.4914.130.270.79
Gross Profit
742.84515.57290.52219.532.525.9
Selling, General & Admin
313.76232.03154.3122.7195.48128.09
Research & Development
236.22160.2294.2976.19125.35222.58
Operating Expenses
549.98392.25248.59198.9220.84350.67
Operating Income
192.86123.3241.9320.63-218.32-344.77
Interest Expense
-46.59-26.73-24.03-12.62-10.19-5.64
Other Non Operating Income (Expenses)
12.4310.797.695.044.72.31
Pretax Income
149.55107.3925.5913.06-223.81-348.1
Income Tax Expense
43.49-339.792.210.39--
Net Income
106.06447.1823.3812.67-223.81-348.1
Net Income to Common
106.06447.1823.3812.67-223.81-348.1
Net Income Growth
-76.30%1812.41%84.52%---
Shares Outstanding (Basic)
141144145142135132
Shares Outstanding (Diluted)
158161160149135132
Shares Change
-2.16%0.67%7.96%9.67%2.41%14.64%
EPS (Basic)
0.753.100.160.09-1.65-2.63
EPS (Diluted)
0.662.770.150.09-1.65-2.63
EPS Growth
-76.21%1746.67%68.03%---

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
85.56-24.99-40.56-31.41-176.18-296.04
Free Cash Flow Per Share
0.54-0.15-0.25-0.21-1.30-2.24
Gross Margin
82.74%83.66%88.30%93.95%90.48%88.19%
Operating Margin
21.48%20.01%12.74%8.83%-7838.99%-5154.28%
Profit Margin
11.81%72.56%7.11%5.42%-8036.34%-5204.08%
Free Cash Flow Margin
9.53%-4.05%-12.33%-13.44%-6326.18%-4425.70%
EBITDA
193.04123.384220.84-218.01-344.49
EBITDA Margin
21.50%20.02%12.77%8.92%--
D&A For EBITDA
0.180.060.070.210.30.28
EBIT
192.86123.3241.9320.63-218.32-344.77
EBIT Margin
21.48%20.01%12.74%8.83%--
Effective Tax Rate
29.08%-8.64%2.99%--
Revenue as Reported
897.76616.29329233.662.796.69
SEC Filings: 10-K · 10-Q